Webinar: Funding Cancer R&D with Non-dilutive Capital; an Emphasis on NIH Sources
NIH alone awards roughly $5.5B annually to Cancer related R&D grants and contracts. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation.
In the upcoming webinar in the series of summer educational webinars, FreeMind’s VP, Ayal Ronen, will discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for Life Science organizations.
Specifically Mr. Ronen will cover:
- NCI overview – mission and goals
- Interesting statistics on cancer funding
- Specific funding opportunities
- Regulations, limitations and major challenges in applying
- How to maximize chances for award
Leave a Reply
Want to join the discussion?Feel free to contribute!